Aggressive Man‐Made Red Blood Cells for Hypoxia‐Resistant Photodynamic Therapy
Top Cited Papers
- 17 July 2018
- journal article
- research article
- Published by Wiley in Advanced Materials
- Vol. 30 (35) , e1802006
Abstract
Extreme hypoxia of tumors represents the most notable barrier against the advance of tumor treatments. Inspired by the biological nature of red blood cells (RBCs) as the primary oxygen supplier in mammals, an aggressive man‐made RBC (AmmRBC) is created to combat the hypoxia‐mediated resistance of tumors to photodynamic therapy (PDT). Specifically, the complex formed between hemoglobin and enzyme‐mimicking polydopamine, and polydopamine‐carried photosensitizer is encapsulated inside the biovesicle that is engineered from the recombined RBC membranes. The mean corpuscular hemoglobin of AmmRBCs reaches about tenfold as high as that of natural RBCs. Owing to the same origin of outer membranes, AmmRBCs share excellent biocompatibility with parent RBCs. The introduced polydopamine plays the role of the antioxidative enzymes existing inside RBCs to effectively prevent the oxygen‐carrying hemoglobin from the oxidation damage during the circulation. This biomimetic engineering can accumulate in tumors, permit in situ efficient oxygen supply, and impose strong PDT efficacy toward the extremely hypoxic tumor with complete tumor elimination. The man‐made pseudo‐RBC shows potentials as a universal oxygen‐self‐supplied platform to sensitize hypoxia‐limited tumor treatment means, including but not limited to PDT. Meanwhile, this study offers ideas to the production of artificial substitutes of packed RBCs for clinical blood transfusion.Keywords
Funding Information
- National Natural Science Foundation of China (51690152, 51533006, 21721005, 21374085)
This publication has 55 references indexed in Scilit:
- Drug encapsulated polymeric microspheres for intracranial tumor therapy: A review of the literatureAdvanced Drug Delivery Reviews, 2015
- Design of Hybrid MnO2‐Polymer‐Lipid Nanoparticles with Tunable Oxygen Generation Rates and Tumor Accumulation for Cancer TreatmentAdvanced Functional Materials, 2015
- Polydopamine and Eumelanin: From Structure–Property Relationships to a Unified Tailoring StrategyAccounts of Chemical Research, 2014
- Human serum albumin and other proteins as templating agents for the synthesis of nanosized dopamine-eumelaninJournal of Colloid and Interface Science, 2014
- Role of integrated cancer nanomedicine in overcoming drug resistanceAdvanced Drug Delivery Reviews, 2013
- Root Effect Hemoglobin May Have Evolved to Enhance General Tissue Oxygen DeliveryScience, 2013
- Dopamine‐Melanin Colloidal Nanospheres: An Efficient Near‐Infrared Photothermal Therapeutic Agent for In Vivo Cancer TherapyAdvanced Materials, 2012
- Nitric Oxide Scavenging by Red Blood Cell Microparticles and Cell-Free Hemoglobin as a Mechanism for the Red Cell Storage LesionCirculation, 2011
- Particle shape: A new design parameter for micro- and nanoscale drug delivery carriersJournal of Controlled Release, 2007
- Hematologic differences between African-Americans and whites: the roles of iron deficiency and α-thalassemia on hemoglobin levels and mean corpuscular volumeBlood, 2005